Community Research and Development Information Service - CORDIS

Self-amplifying RNA technology applied to the development of a universal influenza vaccine

From 2014-04-01 to 2016-03-31, closed project

Project details

Total cost:

EUR 187 414,80

EU contribution:

EUR 187 414,80

Coordinated in:

Italy

Call for proposal:

FP7-PEOPLE-2013-IEFSee other projects for this call

Funding scheme:

MC-IEF - Intra-European Fellowships (IEF)

Objective

Coordinator

GLAXOSMITHKLINE VACCINES SRL
Italy

EU contribution: EUR 187 414,80


VIA FIORENTINA 1
53100 SIENA
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative contact: Francesco Siciliano
Tel.: +39 0577 24 5239
Fax: +39 0577 24 3074
E-mail
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top